Cite
HARVARD Citation
Singer, C. et al. (2020). Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34). European journal of cancer. pp. 43-52. [Online].